Skip to main content

Regulus Therapeutics Inc.

RGLSDelisted Jun 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001505512

Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.

13F holders, Q2 2021

Institutional positions in Regulus Therapeutics Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+1 vs. Q1 2021
Shares held
23.1M
−4.22M (−15.5%) vs. Q1 2021
Total value
$18.7M
−$23.8M (−56.0%) vs. Q1 2021
New holders
13
14 more added
Sold out
12
4 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 45 institutions
Q1 2021: 44 institutionsQ2 2021: 45 institutionsQ3 2021: 42 institutionsQ4 2021: 38 institutionsQ1 2022: 37 institutionsQ2 2022: 28 institutionsQ3 2022: 25 institutionsQ4 2022: 28 institutionsQ1 2023: 27 institutionsQ2 2023: 26 institutionsQ3 2023: 25 institutionsQ4 2023: 26 institutionsQ1 2024: 45 institutionsQ2 2024: 63 institutionsQ3 2024: 70 institutionsQ4 2024: 69 institutionsQ1 2025: 75 institutionsQ2 2025: 1 institutionQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2021: $18.7M
Q1 2021: $42.6MQ2 2021: $18.7MQ3 2021: $15.9MQ4 2021: $9.54MQ1 2022: $18.1MQ2 2022: $12.6MQ3 2022: $13.8MQ4 2022: $11.1MQ1 2023: $6.82MQ2 2023: $15.0MQ3 2023: $15.0MQ4 2023: $14.2MQ1 2024: $147.3MQ2 2024: $109.5MQ3 2024: $89.1MQ4 2024: $84.5MQ1 2025: $107.0MQ2 2025: $760Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RGLS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20251$760
Q1 202575$107.0M
Q4 202469$84.5M
Q3 202470$89.1M
Q2 202463$109.5M
Q1 202445$147.3M
Q4 202326$14.2M
Q3 202325$15.0M
Q2 202326$15.0M
Q1 202327$6.82M
Q4 202228$11.1M
Q3 202225$13.8M
Q2 202228$12.6M
Q1 202237$18.1M
Q4 202138$9.54M
Q3 202142$15.9M
Q2 202145$18.7M
Q1 202144$42.6M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q1 2021.

Institutions holding RGLS in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
NEA Management Company, LLC6,451,056$5.22M0.07%00.0%Unchanged
Vanguard Group Inc3,095,237$2.52M0.00%−125,521−3.9%Reduced
Endurant Capital Management LP2,607,674$2.12M0.58%+231,117+9.7%Added
Victory Capital Management Inc2,237,942$1.82M0.00%+10,743+0.5%Added
Sarissa Capital Management LP1,851,851$1.51M0.12%00.0%Unchanged
Asymmetry Capital Management, L.P.1,450,777$1.18M0.81%−534,695−26.9%Reduced
Ikarian Capital, LLC1,245,989$1.01M0.18%00.0%Unchanged
Acadian Asset Management LLC605,018$492.0K0.00%+139,340+29.9%Added
Geode Capital Management, LLC589,196$479.0K0.00%+207,304+54.3%Added
Morgan Stanley499,625$406.0K0.00%+336,374+206.0%Added
Citadel Advisors LLC279,735$227.0K0.00%+253,811+979.1%Added
Gsa Capital Partners LLP206,265$168.0K0.02%+206,265New
Bank of America Corp204,186$166.0K0.00%−285,076−58.3%Reduced
Focused Wealth Management, Inc200,000$163.0K0.03%+100,000+100.0%Added
Group One Trading, L.P.193,561$157.0K0.00%+179,693+1,295.7%Added
State Street Corp176,494$144.0K0.00%+176,494New
Boothbay Fund Management, LLC141,629$115.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP125,293$102.0K0.00%+125,293New
Northern Trust Corp117,654$96.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)91,872$75.0K0.00%+47,066+105.0%Added
Commonwealth Equity Services, LLC80,000$65.0K0.00%+60,000+300.0%Added
Virtu Financial LLC79,193$64.0K0.01%+79,193New
Strategic Wealth Advisors Group, LLC74,800$61.0K0.00%+74,800New
Grimes & Company, Inc.63,262$51.0K0.00%+2,271+3.7%Added
Jane Street Group, LLC59,432$48.0K0.00%+45,254+319.2%Added
Lido Advisors, LLC57,500$47.0K0.00%+57,500New
GYL Financial Synergies, LLC41,000$33.0K0.02%−10,376−20.2%Reduced
Two Sigma Securities, LLC37,741$31.0K0.01%+37,741New
Zacks Investment Management28,346$23.0K0.00%+28,346New
McGuire Investment Group, LLC24,000$20.0K0.00%00.0%Unchanged
Pinz Capital Management, LP22,300$18.0K0.01%+22,300New
Simplex Trading, LLC20,323$16.0K0.00%+20,323New
Creative Planning14,200$12.0K0.00%+2,200+18.3%Added
All Terrain Financial Advisors, LLC15,000$12.0K0.01%+15,000New
WealthTrust Axiom LLC13,000$10.0K0.00%00.0%Unchanged
Dowling & Yahnke LLC12,000$10.0K0.00%00.0%Unchanged
Blair William & Co10,700$9.00K0.00%00.0%Unchanged
Manufacturers Life Insurance Company, The10,610$9.00K0.00%+10,610New
Wells Fargo & Company7,632$6.00K0.00%+127+1.7%Added
Royal Bank of Canada7,063$6.00K0.00%00.0%Unchanged
Community Bank, N.A.6,900$6.00K0.00%00.0%Unchanged
Endurance Wealth Management, Inc.6,750$5.00K0.00%00.0%Unchanged
BlackRock Inc.2,320$2.00K0.00%00.0%Unchanged
Sonora Investment Management, LLC16$00.00%00.0%Unchanged
FMR LLC3$00.00%+3New
Point72 Asset Management, L.P.0$00.00%−3,215,436−100.0%Sold out
Two Sigma Investments, LP0$00.00%−1,070,209−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−842,600−100.0%Sold out
Atom Investors LP0$00.00%−337,228−100.0%Sold out
Squarepoint Ops LLC0$00.00%−159,804−100.0%Sold out
Marshall Wace, LLP0$00.00%−51,692−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−26,759−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−18,049−100.0%Sold out
Private Advisor Group, LLC0$00.00%−10,000−100.0%Sold out
Valeo Financial Advisors, LLC0$00.00%−4,225−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−1,000−100.0%Sold out
Federation des caisses Desjardins du Quebec0$00.00%−83−100.0%Sold out